Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

William W. Busse, Jonathan Corren, Bobby Q. Lanier et al. · Journal of Allergy and Clinical Immunology · 2001 · 1.3K citations · Full text

Life Sciences, Immunology, Pharmacology +16

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics

M. Solèr, Jonathan Matz, Robert G. Townley et al. · European Respiratory Journal · 2001 · 826 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis

Elizabeth F. Juniper, Gordon Guyatt · Clinical & Experimental Allergy · 1991 · 809 citations

Life Sciences, Internal Medicine, Allergy +12

Diagnosis and Management of Rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology

Mark S. Dykewicz, Stanley M. Fìneman, David P. Skoner et al. · Annals of Allergy Asthma & Immunology · 1998 · 659 citations

Life Sciences, Clinical Sciences, Immunology +16

Treatment of Childhood Asthma With Anti-Immunoglobulin E Antibody (Omalizumab)

Henry Milgrom, William Berger, Anjuli Nayak et al. · PEDIATRICS · 2001 · 519 citations

Life Sciences, Immunology, Pediatrics +17